Taylor Frigon Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.14M Sell
120,231
-7,317
-6% -$130K 1.14% 42
2025
Q1
$2.27M Sell
127,548
-15,894
-11% -$283K 1.35% 17
2024
Q4
$4.27M Sell
143,442
-16,604
-10% -$495K 2.16% 3
2024
Q3
$2.5M Buy
160,046
+26,748
+20% +$418K 1.25% 29
2024
Q2
$2.28M Buy
133,298
+6,384
+5% +$109K 1.09% 37
2024
Q1
$1.98M Buy
126,914
+30,057
+31% +$470K 0.95% 45
2023
Q4
$1.45M Buy
96,857
+5,422
+6% +$81K 0.73% 59
2023
Q3
$1.48M Buy
91,435
+24,790
+37% +$400K 0.82% 52
2023
Q2
$2.77M Buy
66,645
+25,244
+61% +$1.05M 1.35% 28
2023
Q1
$2.49M Sell
41,401
-660
-2% -$39.7K 1.36% 26
2022
Q4
$3.09M Sell
42,061
-2,857
-6% -$210K 1.75% 16
2022
Q3
$3.41M Sell
44,918
-23,990
-35% -$1.82M 1.78% 12
2022
Q2
$4.79M Sell
68,908
-4,106
-6% -$285K 2.49% 6
2022
Q1
$6.05M Buy
73,014
+26,638
+57% +$2.21M 2.25% 9
2021
Q4
$3.48M Buy
46,376
+528
+1% +$39.6K 1.09% 36
2021
Q3
$5.33M Buy
45,848
+14,813
+48% +$1.72M 1.72% 22
2021
Q2
$6.88M Sell
31,035
-17,614
-36% -$3.91M 2.15% 6
2021
Q1
$6.43M Sell
48,649
-341
-0.7% -$45.1K 1.98% 14
2020
Q4
$8.48M Buy
48,990
+2,094
+4% +$362K 2.78% 4
2020
Q3
$5.22M Buy
46,896
+592
+1% +$65.9K 2.3% 5
2020
Q2
$2.75M Buy
46,304
+3,402
+8% +$202K 1.36% 30
2020
Q1
$2.89M Buy
42,902
+4,829
+13% +$325K 2.26% 7
2019
Q4
$3.21M Sell
38,073
-3,125
-8% -$263K 2.21% 4
2019
Q3
$3.08M Sell
41,198
-5,401
-12% -$404K 2.23% 4
2019
Q2
$2.95M Buy
46,599
+4,110
+10% +$260K 2.04% 8
2019
Q1
$2.05M Sell
42,489
-1,197
-3% -$57.7K 1.59% 20
2018
Q4
$1.46M Buy
+43,686
New +$1.46M 1.29% 37